Zelman M E, Lange C F
Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois 60153, USA.
Hybridoma. 1995 Dec;14(6):529-36. doi: 10.1089/hyb.1995.14.529.
Pursuing an autoimmune model for the etiology of poststreptococcal glomerulonephritis, protein antigens isolated from the cytoplasmic membrane of nephritogenic group A Type 12 Streptococcus pyogenes were immunochemically characterized using antistreptococcal cell membrane (SCM) monoclonal antibody (MAb) cross-reactive with glomerular basement membrane (GBM). Low molecular weight (9.2, 7.0, 4.7, 2.3 kDa) HPLC-purified SCM polypeptide antigens were characterized by competitive inhibition and equilibrium dialysis. Competitive inhibition of the MAb, by different sized SCM polypeptide antigens showed an inverse relationship between the size of these antigens and the molar amount required to obtain 50% inhibition of the MAb, confirming previous observations that suggested that these SCM antigens exhibit increasing epitope concentration with increasing size, that is constant epitope density. The observed changes in epitope concentration correlated with differences in the valence and affinity of the MAb as determined by equilibrium dialysis. The Kds of the MAb for 9.2-, 7.0-, 4.7-, and 2.3-kDa SCM antigens ranged from 7.42 x 10(-7) to 1.15 x 10(-5). The experimentally determined MAb valence for these antigens was 2 for the 9.2-kDa antigen and approached 10 for the smaller antigens. Finally, the similarity of these SCM antigens was reflected in similar amino acid compositions; of note, these data agreed with the compositions previously reported for sized GBM antigens. Concentrations of Asp, Thr, Ser, Glu, Gly, Ala, Val, Ile, and Leu paralleled increasing epitope concentration. Apparent N-terminal blocking prevented sequencing of these peptides, but these immunochemical data suggest that intact SCM antigen recognized by the anti-SCM MAb consists of repeating epitopes, an observation consistent with the cytoplasmic membrane source of the antigen.
为了探究链球菌感染后肾小球肾炎病因的自身免疫模型,使用与肾小球基底膜(GBM)交叉反应的抗链球菌细胞膜(SCM)单克隆抗体(MAb),对从致肾炎A组12型化脓性链球菌细胞质膜中分离出的蛋白质抗原进行免疫化学特征分析。通过竞争抑制和平衡透析对经高效液相色谱(HPLC)纯化的低分子量(9.2、7.0、4.7、2.3 kDa)SCM多肽抗原进行特征分析。不同大小的SCM多肽抗原对MAb的竞争抑制显示,这些抗原的大小与获得50% MAb抑制所需的摩尔量呈反比关系,这证实了先前的观察结果,即这些SCM抗原的表位浓度随大小增加而增加,即表位密度恒定。观察到的表位浓度变化与通过平衡透析确定的MAb的价态和亲和力差异相关。MAb对9.2 kDa、7.0 kDa、4.7 kDa和2.3 kDa SCM抗原的解离常数(Kd)范围为7.42×10⁻⁷至1.15×10⁻⁵。实验确定这些抗原的MAb价态对于9.2 kDa抗原为2,对于较小的抗原接近10。最后,这些SCM抗原的相似性反映在相似的氨基酸组成中;值得注意的是,这些数据与先前报道的大小GBM抗原的组成一致。天冬氨酸、苏氨酸、丝氨酸、谷氨酸、甘氨酸、丙氨酸、缬氨酸、异亮氨酸和亮氨酸的浓度与表位浓度增加平行。明显的N端封闭阻止了这些肽的测序,但这些免疫化学数据表明,抗SCM MAb识别的完整SCM抗原由重复表位组成,这一观察结果与抗原的细胞质膜来源一致。